Business Context and Reporting Period
This Form 8-K is filed by ReWalk Robotics Ltd. (trading symbol: RWLK) on October 6, 2023. The company, incorporated in Israel, develops personal exoskeleton products. The report addresses a critical regulatory event regarding the company's continued listing on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on compliance with listing standards rather than financial performance metrics.
Material Changes and Events
- Delisting Notice: On October 6, 2023, Nasdaq notified ReWalk that its securities are subject to delisting due to non-compliance with the minimum bid price requirement (Nasdaq Listing Rule 5550(a)).
- Compliance History: The company failed to maintain a minimum $1.00 closing bid price for 30 consecutive business days ending October 5, 2023. This followed the expiration of two consecutive 180-calendar day grace periods granted after an initial notice on October 10, 2022.
- Current Status: Securities will continue to trade on Nasdaq pending the conclusion of the hearing process.
Outlook, Management Commentary, and Risks
- Compliance Plan: ReWalk plans to request a hearing before the Nasdaq Hearings Panel to present a plan to regain compliance. This plan may include a reverse stock split if deemed necessary.
- Strategic Catalyst: The company is seeking an extension to align with the finalization of a Centers for Medicare & Medicaid Services (CMS) administrative proposal. This rule, expected to be published in November 2023 and effective January 1, 2024, would explicitly include exoskeletons within a Medicare benefit category, potentially expanding the U.S. addressable market.
- Risks: There is no assurance that the Panel will grant the request for continued listing or that the company will regain compliance within any granted extension. The filing references significant risks regarding delisting consequences detailed in the company's 2022 Form 10-K.
Investor Verification Checklist
- Confirm the date and outcome of the hearing before the Nasdaq Hearings Panel.
- Monitor the publication date of the CMS home health rule and its specific inclusion of exoskeletons.
- Watch for announcements regarding a potential reverse stock split to address the bid price requirement.
- Review the "Risk Factors" section of the company's most recent Form 10-K for detailed consequences of delisting.